Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Berger

Showing results (911-920 of 964) with videos related to

Pageof 97
Sort By:
Andrology|January 28, 2026
Effects of Low-to-Moderate Ionizing Radiation on Human Sperm Function and DNA IntegrityOriana Carcy, Nicolas Sas, Marion Chanchou, et al.
The British Journal of Dermatology|August 2, 2008
A newly identified splice site mutation in ZMPSTE24 causes restrictive dermopathy in the Middle EastC S Sander, N Salman, M van Geel, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|June 11, 2016
Gestational and Early Postnatal Exposure to an Environmentally Relevant Mixture of Brominated Flame Retardants: General Toxicity and Skeletal VariationsEmily W Y Tung, Han Yan, Pavine L C Lefèvre, et al.
Cancer Research|August 4, 2004
Immunogenicity of constitutively active V599EBRafMads Hald Andersen, Joachim Fensterle, Selma Ugurel, et al.
Cancers|October 14, 2022
The Spliceosome: A New Therapeutic Target in Chronic Myeloid LeukaemiaBenjamin Lebecque, Celine Bourgne, Chinmay Munje, et al.
Diabetes/Metabolism Research and Reviews|April 27, 2005
Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locusRachel Miller-Lotan, Yehuda Herskowitz, Shiri Kalet-Litman, et al.
Life Sciences|March 9, 1999
SCH 57790: a novel M2 receptor selective antagonistJ E Lachowicz, D Lowe, R A Duffy, et al.
Molecular Oncology|March 26, 2018
DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34<sup>+</sup> CD15<sup>-</sup> cells in early chronic-phase chronic myeloid leukemiaStéphanie Maupetit-Mehouas, Franck Court, Céline Bourgne, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 9, 2022
A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastomaJ L Jimenez-Macias, Y-C Lee, E Miller, et al.
Haematologica|May 2, 2024
The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohortSandrine Saugues, Céline Lambert, Elisabeth Daguenet, et al.
Pageof 97

Showing results (911-920 of 964) with videos related to

Sort By:
Pageof 97
Andrology|January 28, 2026
Effects of Low-to-Moderate Ionizing Radiation on Human Sperm Function and DNA IntegrityOriana Carcy, Nicolas Sas, Marion Chanchou, et al.
The British Journal of Dermatology|August 2, 2008
A newly identified splice site mutation in ZMPSTE24 causes restrictive dermopathy in the Middle EastC S Sander, N Salman, M van Geel, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|June 11, 2016
Gestational and Early Postnatal Exposure to an Environmentally Relevant Mixture of Brominated Flame Retardants: General Toxicity and Skeletal VariationsEmily W Y Tung, Han Yan, Pavine L C Lefèvre, et al.
Cancer Research|August 4, 2004
Immunogenicity of constitutively active V599EBRafMads Hald Andersen, Joachim Fensterle, Selma Ugurel, et al.
Cancers|October 14, 2022
The Spliceosome: A New Therapeutic Target in Chronic Myeloid LeukaemiaBenjamin Lebecque, Celine Bourgne, Chinmay Munje, et al.
Diabetes/Metabolism Research and Reviews|April 27, 2005
Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locusRachel Miller-Lotan, Yehuda Herskowitz, Shiri Kalet-Litman, et al.
Life Sciences|March 9, 1999
SCH 57790: a novel M2 receptor selective antagonistJ E Lachowicz, D Lowe, R A Duffy, et al.
Molecular Oncology|March 26, 2018
DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34<sup>+</sup> CD15<sup>-</sup> cells in early chronic-phase chronic myeloid leukemiaStéphanie Maupetit-Mehouas, Franck Court, Céline Bourgne, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 9, 2022
A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastomaJ L Jimenez-Macias, Y-C Lee, E Miller, et al.
Haematologica|May 2, 2024
The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohortSandrine Saugues, Céline Lambert, Elisabeth Daguenet, et al.
Pageof 97